![Luca Quagliata](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Luca Quagliata
Investitore di Private Equity presso Xgen Venture Sgr SpA
Profilo
Dr Luca Quagliata joined XGEN as Venture Partner in 2023.
Luca is VP and Global Head of Medical Affairs for the Genetic Science Group at Thermo Fisher Scientific.
Before joining Thermo Fisher, Luca worked as Senior Director and Team Leader of the Molecular Diagnostics Division at the Institute of Pathology, University Hospital Basel, Switzerland.
Luca is trained in Medical Biotechnology (Naples, Italy), holds a Ph.D.
in Vascular Medicine (Heidelberg, Germany), a Certificate of Achievement (COA) in Genetics (Harvard, Boston), was a visiting fellow at the NCI-NIH (Bethesda, USA), and is a Board-Certified Specialist in Medical Affairs (BCMAS).
Posizioni attive di Luca Quagliata
Società | Posizione | Inizio |
---|---|---|
Xgen Venture Sgr SpA
![]() Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Investitore di Private Equity | 01/01/2023 |
Formazione di Luca Quagliata
Heidelberg University (Ohio) | Doctorate Degree |
Università degli Studi di Napoli Federico II | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Xgen Venture Sgr SpA
![]() Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Finance |
- Borsa valori
- Insiders
- Luca Quagliata